MP-1 (University of Nebraska Medical Center/Shenyang Pharmaceutical University/University of California)

N/A

Report date: 2025/03/20 15:01:21
NME

Base Information

Drug NameMP-1 (University of Nebraska Medical Center/Shenyang Pharmaceutical University/University of California)
Drug Alias Namepyrrolomycin-based anticancer agents (UNMC/Shenyang Pharmaceutical University/UCSD)MP-1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeuroblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsNeuroblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A